BDTX
Black Diamond Therapeutics Inc
NASDAQ: BDTX · HEALTHCARE · BIOTECHNOLOGY
$2.65
+3.11% today
Updated 2026-04-30
Market cap
$170.15M
P/E ratio
7.62
P/S ratio
2.43x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$1 – $5
Volume
0.7M
Black Diamond Therapeutics Inc (BDTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
32.00%
Operating margin
28.40%
ROE
22.90%
ROA
9.35%
Debt/equity
0.13x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2017 | $0.00 | $-4.60M | — | — | — |
| 2018 | $0.00 | $-8.93M | — | — | — |
| 2019 | $0.00 | $-35.26M | — | — | — |
| 2020 | $0.00 | $-67.25M | — | — | — |
| 2021 | $0.00 | $-125.60M | — | — | — |
| 2022 | $0.00 | $-91.17M | — | — | — |
| 2023 | $0.00 | $-82.44M | — | — | — |
| 2024 | $0.00 | $-69.68M | — | — | — |
| 2025 | $70.00M | $22.37M | 99.54% | 28.39% | 31.95% |